Contract for Rubber Expansion Joints at Zhejiang Huahai Pharmaceutical Xunqiao Plant
Shanghai Songjiang Vibration Absorber Co.,Ltd. official website introduces: “Contract Information for Rubber Expansion Joints at Zhejiang Huahai Pharmaceutical Xunqiao Plant”. Songjiang Group provides pipeline shock absorbers for numerous pharmaceutical factories, installed at the pump inlets and outlets, with excellent shock absorption and noise reduction effects.
1. Introduction to Zhejiang Huahai Pharmaceutical:
Zhejiang Huahai Pharmaceutical Co., Ltd. was founded in 1989, formerly known as Linhai Xunqiao Synthetic Chemical Plant. In January 2001, it was restructured and established as Zhejiang Huahai Pharmaceutical Co., Ltd. In March 2003, the company’s stocks were successfully listed on the Shanghai Stock Exchange. Zhejiang Huahai Pharmaceutical Co., Ltd. is a national high-tech enterprise, an innovative enterprise recognized by the state, and one of the key enterprises confirmed by the provincial government. It has a national-level enterprise technology center and a postdoctoral research workstation. It is the first pharmaceutical enterprise in the country to be awarded the title of “National Environmentally Friendly Enterprise”. From 2000 to 2008, it was ranked among the “Top Ten Pharmaceutical Industries in Zhejiang Province” for nine consecutive years.
The company has a registered capital of 299 million yuan, total assets of 1.7 billion yuan, covers an area of over 800,000 square meters, and has more than 2,800 employees. It has established 11 subsidiaries in Linhai, Hangzhou, Shanghai, and the United States.
The main business of the company includes pharmaceutical preparations, APIs, and intermediates, forming a product structure with a clear focus on cardiovascular drugs, antidepressants, and antiviral drugs. Among them, ACE inhibitors, a cardiovascular drug, have the most varieties, the largest production and sales volume internationally, and leading technology, enjoying the reputation of “Pril Expert”. The company has a sound management system, and all products have passed the national GMP certification. It is one of the enterprises in China that has passed the most international drug quality certifications.
In June 2007, the company’s anti-AIDS drug, nevirapine, passed the U.S. FDA certification with zero defects, making it the first pharmaceutical company in China to obtain this certification. It obtained a pass to enter the high-end markets in Europe and the United States for Huahai’s preparations and filled the gap in the export of Chinese preparation products to the United States, establishing a remarkable milestone in the development history of China’s pharmaceutical industry.
The company was approved by the Zhejiang Provincial People’s Government Enterprise Listing Leading Group’s Zhejiang Listing [2001] No. 5 document on January 19, 2001, and was jointly initiated by the shareholders of the former Zhejiang Huahai Pharmaceutical Group Co., Ltd., Chen Baohua, Zhou Minghua, Tsinghua Unisplendour Technology Innovation Investment Co., Ltd., Beijing Oriental Classic Business Consultant Co., Ltd., Zhejiang Meiyang International Petrochemical Pharmaceutical Engineering Design Co., Ltd., Ningbo Taida Import and Export Co., Ltd., and Shi Huilin. It was registered and established as a joint-stock company on February 28, 2001, with the Zhejiang Provincial Administration for Industry and Commerce. On January 28, 2003, it was approved by the China Securities Regulatory Commission’s [2003] No. 11 document, and the company publicly issued 35 million shares of A-shares.
2. Introduction to the Rubber Expansion Joint Contract at Zhejiang Huahai Pharmaceutical Xunqiao Plant:
The following is a scanned copy of the authentic contract. Please do not modify or reproduce. This contract is only used as a proof of supply. Thank you for your cooperation.
3. Photo of Rubber Expansion Joint at Zhejiang Huahai Pharmaceutical Xunqiao Plant:
Related link: Hospital Rubber Expansion Joint Case Study
